Equities analysts forecast that Acadia Healthcare Company, Inc. (NASDAQ:ACHC) will post earnings of $0.55 per share for the current fiscal quarter, Zacks reports. Eight analysts have issued estimates for Acadia Healthcare’s earnings. The highest EPS estimate is $0.56 and the lowest is $0.54. Acadia Healthcare posted earnings of $0.59 per share in the same quarter last year, which would suggest a negative year-over-year growth rate of 6.8%. The company is scheduled to report its next earnings report on Thursday, February 22nd.

On average, analysts expect that Acadia Healthcare will report full year earnings of $2.23 per share for the current year, with EPS estimates ranging from $2.20 to $2.25. For the next fiscal year, analysts forecast that the business will post earnings of $2.44 per share, with EPS estimates ranging from $2.27 to $2.63. Zacks’ EPS calculations are a mean average based on a survey of research analysts that follow Acadia Healthcare.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Tuesday, October 24th. The company reported $0.58 earnings per share for the quarter, missing the consensus estimate of $0.65 by ($0.07). The company had revenue of $716.70 million during the quarter, compared to analyst estimates of $728.86 million. Acadia Healthcare had a net margin of 6.07% and a return on equity of 8.57%. The company’s quarterly revenue was down 2.4% on a year-over-year basis. During the same period in the previous year, the company posted $0.58 EPS.

Several brokerages recently commented on ACHC. Zacks Investment Research lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, October 2nd. Jefferies Group set a $60.00 target price on Acadia Healthcare and gave the company a “buy” rating in a research report on Wednesday, October 11th. BMO Capital Markets began coverage on Acadia Healthcare in a research report on Monday, October 16th. They set an “outperform” rating and a $52.00 target price on the stock. KeyCorp restated a “buy” rating and set a $59.00 target price on shares of Acadia Healthcare in a research report on Friday, October 20th. Finally, Cantor Fitzgerald cut their target price on Acadia Healthcare from $48.00 to $39.00 and set a “neutral” rating on the stock in a research report on Tuesday, October 24th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and nine have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $45.08.

In other Acadia Healthcare news, Director Reeve B. Waud sold 100,000 shares of the stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $31.80, for a total value of $3,180,000.00. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 11.10% of the stock is currently owned by corporate insiders.

A number of large investors have recently made changes to their positions in ACHC. Schwab Charles Investment Management Inc. boosted its holdings in Acadia Healthcare by 13.8% in the second quarter. Schwab Charles Investment Management Inc. now owns 330,515 shares of the company’s stock worth $16,321,000 after acquiring an additional 40,119 shares in the last quarter. SG Americas Securities LLC bought a new position in shares of Acadia Healthcare in the second quarter valued at approximately $280,000. Legal & General Group Plc lifted its holdings in shares of Acadia Healthcare by 130.8% in the second quarter. Legal & General Group Plc now owns 59,435 shares of the company’s stock valued at $2,934,000 after purchasing an additional 33,679 shares in the last quarter. Comerica Bank bought a new position in shares of Acadia Healthcare in the second quarter valued at approximately $2,488,000. Finally, BNP Paribas Arbitrage SA lifted its holdings in shares of Acadia Healthcare by 2,358.9% in the second quarter. BNP Paribas Arbitrage SA now owns 28,843 shares of the company’s stock valued at $1,424,000 after purchasing an additional 27,670 shares in the last quarter.

Shares of Acadia Healthcare (ACHC) traded up $1.18 during mid-day trading on Tuesday, hitting $33.81. The stock had a trading volume of 1,214,863 shares, compared to its average volume of 989,300. The firm has a market capitalization of $2,970.00, a PE ratio of 17.25, a price-to-earnings-growth ratio of 1.21 and a beta of 0.90. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 1.30. Acadia Healthcare has a 12 month low of $26.92 and a 12 month high of $54.34.

ILLEGAL ACTIVITY NOTICE: “Zacks: Brokerages Anticipate Acadia Healthcare Company, Inc. (ACHC) Will Announce Earnings of $0.55 Per Share” was originally published by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright law. The correct version of this piece of content can be read at https://www.americanbankingnews.com/2018/01/02/zacks-brokerages-anticipate-acadia-healthcare-company-inc-achc-will-announce-earnings-of-0-55-per-share.html.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Get a free copy of the Zacks research report on Acadia Healthcare (ACHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.